Hepatocyte Growth Factor (HGF) modulates leydig cell extracellular matrix components

Journal of Andrology

Volumn 31, Issue 3, 2010, Pages 306-313

  Catizone, A ^a   Ricci, G ^b   Tufano, M A ^b   Perfetto, B ^b   Canipari, R ^a   Galdieri, Michaela ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Fibronectin; MMP; TGF ; uPA

Indexed keywords

FIBRONECTIN; GELATINASE A; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA; UROKINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVITY; CELL CULTURE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; LEYDIG CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SPERMATOGENESIS; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; MALE; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ANIMALS; CELLS, CULTURED; EXTRACELLULAR MATRIX; FIBRONECTINS; HEPATOCYTE GROWTH FACTOR; LEYDIG CELLS; MALE; MATRIX METALLOPROTEINASE 2; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR BETA; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 77953931371     PISSN: 01963635     EISSN: 19394640     Source Type: Journal    
DOI: 10.2164/jandrol.109.007658     Document Type: Article

References (49)

1. Abe M, Harpel JG, Metz CN, Nunes I, Loskutoff DJ, Rifkin DB. An assay for transforming growth factor-β using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem. 1994;216(2):276-284.
2. Ariyaratne HB, Chamindrani Mendis-Handagama S. Changes in the testis interstitium of Sprague Dawley rats from birth to sexual maturity. Biol Reprod. 2000;62(3):680-690.
3. Barreiro ML, Gaytan F, Castellano JM, Suominen JS, Roa J, Gaytan M, Aguilar E, Dieguez C, Toppari J, Tena-Sempere M. Ghrelin inhibits the proliferative activity of immature Leydig cells in vivo and regulates stem cell factor messenger ribonucleic acid expression in rat testis. Endocrinology. 2004;145(11)4825-4834.
4. Blasi F, Vassalli JD, Danø K. Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors. J Cell Biol. 1987;104(4): 801-804.
5. Catizone A, Ricci G, Arista V, Galdieri M. Hepatocyte growth factor receptor expression in rat testis. Andrologia. 2000;32(1):59-60.
6. Catizone A, Ricci G, Arista V, Innocenzi A, Galdieri M. Hepatocyte growth factor and c-MET are expressed in rat prepuberal testis. Endocrinology. 1999;140(7):3106-3113.
7. Catizone A, Ricci G, Del Bravo J, Galdieri M. Hepatocyte growth factor modulates in vitro survival and proliferation of germ cells during postnatal testis development. J Endocrinol. 2006;189(1): 137-146.
8. Catizone A, Ricci G, Galdieri M. Expression and functional role of hepatocyte growth factor receptor (C-MET) during postnatal rat testis development. Endocrinology. 2001;142(5):1828-1834.
9. Catizone A, Ricci G, Galdieri M. Functional role of hepatocyte growth factor receptor during sperm maturation. J Androl. 2002;23(6):911-918.
10. Catizone A, Ricci G, Galdieri M. HGF and postnatal testis development. Mol Cell Endocrinol. 2005;241(1-2):32-40.
11. Catizone A, Ricci G, Galdieri M. Hepatocyte growth factor modulates Sertoli-Sertoli tight junction dynamics. J Cell Physiol. 2008;216(1):253-260.
12. Chakraborti S, Mandai M, Das S, Mandai A, Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem. 2003;253(1-2):269-285.
13. Del Bravo J, Catizone A, Ricci G, Galdieri M. Hepatocyte growth factor-modulated rat Leydig cell functions. J Androl. 2007;28(6): 866-874.
14. Dickson C, Webster DR, Johnson H, Cecilia Millena A, Khan SA. Transforming growth factor-β effects on morphology of immature rat Leydig cells. Mol Cell Endocrinol. 2002;195(1-2):65-77.
15. Esposito C, Parrilla B, De Mauri A, Cornacchia F, Fasoli G, Foschi A, Mazzullo T, Plati A, Scudellaro R, Dal Canton A. Hepatocyte growth factor (HGF) modulates matrix turnover in human glomeruli. Kidney Int. 2005;67(6):2143-2150.
16. Ge RS, Hardy MP. Decreased cyclin A2 and increased cyclin G1 levels coincide with loss of proliferative capacity in rat Leydig cells during pubertal development. Endocrinology. 1997;138(9):3719-3726.
17. Gong R, Rifai A, Tolbert EM, Centracchio JN, Dworkin LD. Hepatocyte growth factor modulates matrix metalloproteinases and plasminogen activator/plasmin proteolytic pathways in progressive renal interstitial fibrosis. J Am Soc Nephrol. 2003;14(12): 3047-3060.
18. Granelli-Piperno A, Reich E. A study of proteases and protease-inhibitor complexes in biological fluids. J Exp Med. 1978;148(1): 223-234.
19. Haider SG. Cell biology of Leydig cells in the testis. Int Rev Cytol 2004;233:181-241.
20. Hamasuna R, Kataoka H, Moriyama T, Itoh H, Seiki M, Koono M. Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP. Int J Cancer. 1999;82(2):274-281.
21. Hartmann G, Weidner KM, Schwarz H, Birchmeier W. The motility signal of scatter factor/hepatocyte growth factor mediated through the receptor tyrosine kinase met requires intracellular action of Ras. J Biol Chem. 1994;269(35):21936-21939.
22. Hedger MP, Meinhardt A. Cytokines and the immune-testicular axis. J Reprod Immunol. 2003;58(1):1-26.
23. Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in Polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem. 1980;102(1):196-202.
24. Khan S, Teerds K, Dorrington J. Growth factor requirements for DNA synthesis by Leydig cells from the immature rat. Biol Reprod. 1992;46(3):335-341.
25. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(5259):680-685.
26. Le Magueresse-Battistoni B. Serine proteases and serine protease inhibitors in testicular physiology: the plasminogen activation system. Reproduction. 2007;134(6):721-729.
27. Morris AJ, Taylor MF, Morris ID. Leydig cell apoptosis in response to ethane dimethanesulphonate after both in vivo and in vitro treatment. J Androl. 1997;18(3):274-280.
28. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006;69(3): 562-573.
29. Nunes I, Shapiro RL, Rifkin DB. Characterization of latent TGF-beta activation by murine peritoneal macrophages. J Immunol. 1995;155(3):1450-1459.
30. Odekon LE, Blasi F, Rifkin DB. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta. J Cell Physiol. 1994;158(3):398-407.
31. Odet F, Verot A, Le Magueresse-Battistoni B. The mouse testis is the source of various serine proteases and serine proteinase inhibitors (SERPINs): serine proteases and SERPINs identified in Leydig cells are under gonadotropin regulation. Endocrinology. 2006; 147(9):4374-4383.
32. Overall CM, Wrana JL, Sodek J. Transforming growth factor-β regulation of collagenase, 72 kDa-progelatinase, TIMP and PAI-1 expression in rat bone cell populations and human fibroblasts. Connect Tissue Res. 1989;20(1-4):289-294.
33. Overall CM, Wrana JL, Sodek J. Induction of formative and resorptive cellular phenotypes in human gingival fibroblasts by TGF-beta 1 and concanavalin A: regulation of matrix metalloproteinases and TIMP. J Periodontal Res. 1991;26(3 Pt 2):279-282.
34. Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol. 2007;8(3):221-233.
35. Payne AH, Downing JR, Wong KL. Luteinizing hormone receptors and testosterone synthesis in two distinct populations of Leydig cells. Endocrinology. 1980;106(5):1424-1429.
36. Ricci G, Catizone A, Galdieri M. Pleiotropic activity of hepatocyte growth factor during embryonic mouse testis development. Mech Dev. 2002;118(1-2):19-28.
37. Ricci G, Catizone A, Galdieri M. Embryonic mouse testis development: role of platelet derived growth factor (PDGF-BB). J Cell Physiol. 2004;200(3):458-467.
38. Ricci G, Catizone A, Galdieri M. Expression and functional role of hepatocyte growth factor and its receptor (c-met) during fetal mouse testis development. J Endocrinol. 2006;191(3):559-570.
39. Ricci G, Catizone A, Innocenzi A, Galdieri M. Hepatocyte growth factor (HGF) receptor expression and role of HGF during embryonic mouse testis development. Dev Biol. 1999;216(1): 340-347.
40. Sonnenberg E, Meyer D, Weidner KM, Birchmeier C. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J Cell Biol. 1993;123(1): 223-235.
41. Svechnikov KV, Sultana T, Söder O. Age-dependent stimulation of Leydig cell steroidogenesis by interleukin-1 isoforms. Mol Cell Endocrinol. 2001;182(2):193-201.
42. Vassalli JD, Dayer JM, Wohlwend A, Belin D. Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages. J Exp Med. 1984;159(6):1653-1668.
43. Vassalli JD, Sappino AP, Belin D. The plasminogen activator/plasmin system. J Clin Invest. 1991;88(4):1067-1072.
44. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003;92(8):827-839.
45. Walch L, Morris PL. Cyclooxygenase 2 pathway mediates IL-1β regulation of IL-1α, -1β, and IL-6 mRNA levels in Leydig cell progenitors. Endocrinology. 2002;143(9):3276-3283.
46. Wang H, Keiser JA. Hepatocyte growth factor enhances MMP activity in human endothelial cells. Biochem Biophys Res Commun. 2000;272(3):900-905.
47. Weidner KM, Hartmann G, Naldini L, Comoglio PM, Sachs M, Fonatsch C, Rieder H, Birchmeier W. Molecular characteristics of HGF-SF and its role in cell motility and invasion. EXS. 1993;65:311-328.
48. Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev. 2000;14(2):163-176.
49. Zarnegar R, Michalopoulos GK. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol. 1995;129(5):1177-1180.